Justyna Kelly is currently the Vice President and POINT Chief Operating Officer at Eli Lilly and Company since 2024. Prior to this role, Justyna served as the Chief Executive Officer at the Centre for Probe Development and Commercialization from 2019 to 2020 and held multiple positions at POINT Biopharma, including Chief Operating Officer and Vice President of Medical Isotope Development and Operations from 2021 to 2024. Justyna’s earlier career includes roles such as Manager of Fill/Finish Operations, Sterility Assurance and Microbiology Supervisor, and Pharmaceutical Microbiologist. Justyna earned a Master of Science in Biochemistry from McMaster University in 2010.
This person is not in the org chart
This person is not in any teams
This person is not in any offices